|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | LRG ELISA Assay | Amyloidß (1-43) (FL) ELISA Assay | Androstenedione ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Complement System Screen ELISA Assay |
| Citations | | | | | |
| Catalog Number | 27769 | 27710 | IB79119 | TM09036 | COMPL 300 RUO |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of human LRG in serum, EDTA plasma, urine and cerebrospinal fluid. For research use only, not for use in diagnostic procedures. | Sandwich enzyme-linked immune-sorbent assay (ELISA) for the determination of human Amyloid ß (1-43) in cerebrospinal fluid, brain extract of Tg mouse and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme-linked immunosorbent assay (ELISA) for the determination of Androstenedione in serum and EDTA plasma. FDA exempt, can be used for in-vitro diagnostics. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Wieslab® Complement system Screen kit is an enzyme immunoassay for the determination of functional classical, MBL and alternative complement pathways in human serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Chagas (Trypanosoma cruzi) IgG | Anti-Etanercept (Enbrel®) | 1,3,5(10)-estratriene-3,17ß-diol; 17ß-estradiol; E2. | sAPP Total | Human NfL (Neurofilament light chain) |
| Sample Type | Serum, Blood Plasma | Serum and plasma. | Human serum or plasma (EDTA, lithium heparin, or citrate plasma). | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Cerebrospinal fluids |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.56 to 100 ng/mL | 2.34 to 150 pg/mL | 0.1 to 10.0 ng/mL | Anti-Ustekinumab (Stelara®) | Inquire |
| Sensitivity | 100.0% (95% confidence interval: 95.44% - 100.0%) | 40 ng/mL | 10.6 pg/mL | 0.06 ng/mL | 10.2 pg/mL |
| Assay Time | Overnight + 1 hr (incubation) | Overnight + 1 hr 30 mins (incubation) | 1 hr 30 mins (incubation) | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |